Asherman's Syndrome. Intrauterine synechiae
Conditions
Interventions
Patients with Asherman syndrome After Hysteroscopy and adhesions release, the amniotic membrane is placed on the uterine balloon stent and inserted into the uterus. Then 5cc normal saline is injected
Sponsors
Sarem Fertility and Infertility Research Center
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Asherman's patients with intrauterine adhesions and endometrial atrophy endometrial thickness of less than 5 mm normal functioning of the heart kidneys and lungs wish to complete the study
Exclusion criteria
Exclusion criteria: Unwilling to get pregnant Genital tract inflammation Cardiovascular diseases Hormonal Problems Contraceptive Indication of Relative Hormone Therapy Gastrointestinal diseases prohibits estrogen use liver or chronic hepatic failure Immune system diseases such as lupus, ... Past and present cancer Positive serologic evidence of previous or current hepatitis B and C infection as well as HIV and HTLV
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstruation. Timepoint: At baseline and 3 and 6 months after intervention. Method of measurement: Number of menstruation days, pads number.;Endometrial thickness. Timepoint: At baseline and 3 and 6 months after intervention. Method of measurement: Ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy Rate. Timepoint: 12 month 3 month time frame. Method of measurement: Pregnancy routine tests.;Implantation Rate. Timepoint: Pregnancy routine tests. Method of measurement: Ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. aboTaleb saremi
Sarem Infertility Fertility Research Center
Outcome results
None listed